Cargando…
Novel DNA targeted therapies for head and neck cancers: clinical potential and biomarkers
Head and neck squamous cell carcinoma is the sixth most common cancer worldwide and despite advances in treatment over the last years, there is still a relapse rate of 50%. New therapeutic agents are awaited to increase the survival of patients. DNA repair targeted agents in combination with standar...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655317/ https://www.ncbi.nlm.nih.gov/pubmed/29113422 http://dx.doi.org/10.18632/oncotarget.20953 |